Quarterly report pursuant to Section 13 or 15(d)

PREPAID ASSETS

v2.4.0.8
PREPAID ASSETS
6 Months Ended
Jun. 30, 2014
Prepaid Expense, Current [Abstract]  
Other Current Assets [Text Block]
NOTE E - Prepaid Assets
 
In March 2013, the Company entered into a rights agreement with a manufacturer to insure the use of a dedicated Good Manufacturing Process (GMP) suite to produce Active Pharmaceutical Ingredient (API) for MAT 9001 during the development phase. These right costs of approximately $34,000, which were paid during the nine months ended September 30, 2013 are included in prepaid expenses and will be amortized over 20 months on a straight line basis.